Related Experiment Video
Updated: Feb 7, 2026

Increased Recovery Time and Decreased LPS Administration to Study the Vagus Nerve Stimulation Mechanisms in Limited Inflammatory Responses
Published on: March 29, 2017
Nuciferine inhibits LPS-induced inflammatory response in BV2 cells by activating PPAR-γ
Lina Zhang1, Jinghua Gao1, Peng Tang1
1Department of Neurology, Shaanxi Provincial People's Hospital, and the Third Affiliated Hospital, Xi'an Jiaotong University School of Medicine, Xi'an 710061, China.
Abstract:
Nuciferine, a bioactive component extracted from the lotus leaf, has been reported to have various anti-inflammatory effects. In the present study, we aimed to investigate the anti-inflammatory effects and mechanism of nuciferine on lipopolysaccharide (LPS)-stimulated BV2 microglia cells. The anti-inflammatory activity of nuciferine was measured by ELISA to detect the inflammatory mrdiators secretion in LPS-simulated BV2 microglia cells. The results demonstrated that nuciferine significantly inhibited LPS-induced TNF-α, IL-1β, PGE2 and NO secretion. LPS-induced NF-κB activation was also suppressed by nuciferine. Further studies showed that nuciferine increased the expression of PPAR-γ. Functional aspects were analyzed using PPAR-γ specific inhibitor GW9662, which attenuated the LPS-induced secretion of proinflammatory mediators, such as TNF-α, IL-1β, PGE2, and NO. In conclusion, these results suggested that nuciferine activated PPAR-γ, which subsequently inhibited LPS-induced inflammation in BV2 cells.
Related Concept Videos
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammatory Response II: Inflammatory Exudate and Tissue Repair
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
Inhibition of Cdk Activity
Inflammatory Response I: Vascular and Cellular
Feedback Inhibition
Co-activators and Co-repressors

